Literature DB >> 17646987

Tumor stromal barriers to the success of adoptive T cell therapy.

Vy Phan1, Mary L Disis.   

Abstract

Mesh：

Year:  2007        PMID： 17646987     DOI： 10.1007/s00262-007-0356-6

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN： 0340-7004            Impact factor:   6.968


× No keyword cloud information.
  7 in total

1.  Systemic Analysis of Predictive Biomarkers for Recurrence in Colorectal Cancer Patients Treated with Curative Surgery.

Authors:  Koichiro Mori; Yuji Toiyama; Susumu Saigusa; Hiroyuki Fujikawa; Junichiro Hiro; Minako Kobayashi; Masaki Ohi; Toshimitsu Araki; Yasuhiro Inoue; Koji Tanaka; Yasuhiko Mohri; Masato Kusunoki
Journal:  Dig Dis Sci       Date:  2015-04-04       Impact factor: 3.199

2.  Controlled extracellular matrix degradation in breast cancer tumors improves therapy by trastuzumab.

Authors:  Ines Beyer; Zongyi Li; Jonas Persson; Ying Liu; Ruan van Rensburg; Roma Yumul; Xiao-Bing Zhang; Mien-Chie Hung; André Lieber
Journal:  Mol Ther       Date:  2010-11-16       Impact factor: 11.454

3.  CCL21 and IFNγ recruit and activate tumor specific T cells in 3D scaffold model of breast cancer.

Authors:  Vy Phan-Lai; Forrest M Kievit; Stephen J Florczyk; Kui Wang; Mary L Disis; Miqin Zhang
Journal:  Anticancer Agents Med Chem       Date:  2014-02       Impact factor: 2.505

4.  Three-dimensional scaffolds to evaluate tumor associated fibroblast-mediated suppression of breast tumor specific T cells.

Authors:  Vy Phan-Lai; Stephen J Florczyk; Forrest M Kievit; Kui Wang; Ekram Gad; Mary L Disis; Miqin Zhang
Journal:  Biomacromolecules       Date:  2013-04-03       Impact factor: 6.988

5.  Prognostic impact of FoxP3+ regulatory T cells in relation to CD8+ T lymphocyte density in human colon carcinomas.

Authors:  Harry H Yoon; Jared M Orrock; Nathan R Foster; Daniel J Sargent; Thomas C Smyrk; Frank A Sinicrope
Journal:  PLoS One       Date:  2012-08-06       Impact factor: 3.240

6.  Identification of an immune gene expression signature associated with favorable clinical features in Treg-enriched patient tumor samples.

Authors:  Kevin B Givechian; Kamil Wnuk; Chad Garner; Stephen Benz; Hermes Garban; Shahrooz Rabizadeh; Kayvan Niazi; Patrick Soon-Shiong
Journal:  NPJ Genom Med       Date:  2018-06-13       Impact factor: 8.617

Review 7.  Colorectal Cancer-Infiltrating Regulatory T Cells: Functional Heterogeneity, Metabolic Adaptation, and Therapeutic Targeting.

Authors:  Sonia Aristin Revilla; Onno Kranenburg; Paul J Coffer
Journal:  Front Immunol       Date:  2022-07-08       Impact factor: 8.786
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.